SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-134812
Filing Date
2024-05-09
Accepted
2024-05-09 08:13:57
Documents
16
Period of Report
2024-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d799182d8k.htm   iXBRL 8-K 30952
2 EX-10.1 d799182dex101.htm EX-10.1 44041
3 EX-10.2 d799182dex102.htm EX-10.2 53918
4 EX-99.1 d799182dex991.htm EX-99.1 24536
  Complete submission text file 0001193125-24-134812.txt   317048

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA slrn-20240508.xsd EX-101.SCH 2840
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE slrn-20240508_lab.xml EX-101.LAB 17977
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slrn-20240508_pre.xml EX-101.PRE 11251
19 EXTRACTED XBRL INSTANCE DOCUMENT d799182d8k_htm.xml XML 3633
Mailing Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301 805-871-4300
ACELYRIN, Inc. (Filer) CIK: 0001962918 (see all company filings)

IRS No.: 852406735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41696 | Film No.: 24928712
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)